Tower Research Capital (TRC)’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Buy |
4,045
+2,782
| +220% | +$113K | ﹤0.01% | 1969 |
|
|
2025
Q1 | $64.9K | Buy |
1,263
+759
| +151% | +$39K | ﹤0.01% | 2037 |
|
|
2024
Q4 | $27.9K | Buy |
504
+19
| +4% | +$1.05K | ﹤0.01% | 2944 |
|
|
2024
Q3 | $16K | Sell |
485
-5,359
| -92% | -$176K | ﹤0.01% | 3388 |
|
|
2024
Q2 | $159K | Buy |
5,844
+5,502
| +1,609% | +$150K | ﹤0.01% | 2247 |
|
|
2024
Q1 | $12.4K | Sell |
342
-4,218
| -93% | -$153K | ﹤0.01% | 3482 |
|
|
2023
Q4 | $92.3K | Buy |
4,560
+824
| +22% | +$16.7K | ﹤0.01% | 2708 |
|
|
2023
Q3 | $66.4K | Buy |
3,736
+2,825
| +310% | +$50.2K | ﹤0.01% | 2313 |
|
|
2023
Q2 | $16.5K | Buy |
911
+42
| +5% | +$759 | ﹤0.01% | 3537 |
|
|
2023
Q1 | $11K | Buy |
869
+127
| +17% | +$1.61K | ﹤0.01% | 4268 |
|
|
2022
Q4 | $11K | Sell |
742
-748
| -50% | -$11.1K | ﹤0.01% | 3870 |
|
|
2022
Q3 | $26K | Sell |
1,490
-1,141
| -43% | -$19.9K | ﹤0.01% | 3728 |
|
|
2022
Q2 | $38K | Sell |
2,631
-3,793
| -59% | -$54.8K | ﹤0.01% | 3149 |
|
|
2022
Q1 | $108K | Buy |
6,424
+5,772
| +885% | +$97K | ﹤0.01% | 2147 |
|
|
2021
Q4 | $14K | Buy |
652
+187
| +40% | +$4.02K | ﹤0.01% | 4105 |
|
|
2021
Q3 | $10K | Sell |
465
-708
| -60% | -$15.2K | ﹤0.01% | 4336 |
|
|
2021
Q2 | $34K | Buy |
1,173
+806
| +220% | +$23.4K | ﹤0.01% | 3361 |
|
|
2021
Q1 | $12K | Sell |
367
-278
| -43% | -$9.09K | ﹤0.01% | 4277 |
|
|
2020
Q4 | $27K | Buy |
+645
| New | +$27K | ﹤0.01% | 3667 |
|